WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Praxis Precision Medicines earnings were -$273.0M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest PRAX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$73.9M, up 3.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRAX reported annual earnings of -$182.8M, with 48.3% growth.

PRAX earnings history

Current Revenue
$7.5M
Current Earnings
-$273.0M
Current Profit Margin
-3,658.5%

PRAX Return on Equity

Current Company
-66.9%
Current Industry
-21.2%
Current Market
35.2%
PRAX's Return on Equity (-66.9%)... subscribe to Premium to read more.
High Return on Equity Performance

PRAX undefined

Current Company
-60.3%
Current Industry
-8.7%
PRAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PRAX announces earnings.

PRAX undefined

Current Company
-79.49%
Current Industry
-3.4%
PRAX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRAX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PRAX-$271.87M-$273.04MN/A-$12.96
KRYS$193.29M$198.91M+275.00%$6.90
CDTX-$183.34M-$184.74MN/A-$10.63
MRUS-$398.18M-$381.14MN/A-$5.30
AXSM-$211.35M-$229.53MN/A-$4.67
View Top Biotech Stocks

Praxis Precision Medicines Earnings Reports & History FAQ

What were Praxis Precision Medicines's earnings last quarter?

On PRAX's earnings call on Invalid Date, Praxis Precision Medicines (NASDAQ: PRAX) reported Q3 2025 earnings per share (EPS) of -$3.36, up 22.18% year over year. Total PRAX earnings for the quarter were -$73.93 million. In the same quarter last year, Praxis Precision Medicines's earnings per share (EPS) was -$2.75.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.

Is Praxis Precision Medicines profitable or losing money?

As of the last Praxis Precision Medicines earnings report, Praxis Precision Medicines is currently losing money. Praxis Precision Medicines's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$273.04 million, a 80.8% increase year over year.

What was PRAX's earnings growth in the past year?

As of Praxis Precision Medicines's earnings date in Invalid Date, Praxis Precision Medicines's earnings has grown year over year. PRAX earnings in the past year totalled -$273.04 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.